Assessing Clinical Outcomes in Cutaneous T-cell Lymphoma

Anderson, 1988, Guidelines for reporting outcomes of lymphoma trials, J Clin Oncol, 6, 559, 10.1200/JCO.1988.6.3.559 Cella, 1988, Quality of life during and after cancer treatment, Compr Therapy, 14, 69 Chalmers, 1983, Bias in treatment assignment in controlled clinical trials, N Engl J Med, 309, 1358, 10.1056/NEJM198312013092204 Dixon, 1988, Reporting outcomes in Hodgkin’s disease and lymphoma, J Clin Oncol, 5, 1670, 10.1200/JCO.1987.5.10.1670 Edelson, 1987, Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy, N Engl J Med, 316, 297, 10.1056/NEJM198702053160603 Markman, 1993, Why does a higher response rate to chemotherapy correlate poorly with improved survival?, J Cancer Res Clin Oncol, 119, 700, 10.1007/BF01195339 Miller, 1981, Reporting results of cancer treatment, Cancer, 47, 207, 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6 Rothman, 1994, The continuing unethical use of placebo controls, N Engl J Med, 331, 394, 10.1056/NEJM199408113310611 Sacks, 1982, Randomized versus historical controls for clinical trials, Am J Med, 72, 233, 10.1016/0002-9343(82)90815-4